Glucose control after severe brain injury

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 11, Issue 2, 2008, Pages 134-139

  Oddo, Mauro ^a,b,c   Schmidt, J Michael ^a   Mayer, Stephan A ^a   Chioléro, René L ^b  

^a NewYork Presbyterian Hospital   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain injured patients; Glucose; Insulin; Outcome

Indexed keywords

GLUCOSE; INSULIN;

BRAIN CANCER; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN METABOLISM; CLINICAL PRACTICE; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DISEASE EXACERBATION; DISEASE SEVERITY; EPILEPTIC STATE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; OUTCOME ASSESSMENT; REVIEW; RISK ASSESSMENT; STROKE; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

BLOOD GLUCOSE; BRAIN INJURIES; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PROGNOSIS; TREATMENT OUTCOME;

EID: 40049100652     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3282f37b43     Document Type: Review

References (53)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
2. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461.
3. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988; 241:462-464.
4. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science 1999; 283:496-497.
5. Pellerin L, Magistretti PJ. Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist 2004; 10:53-62.
6. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 2007; 27:1766-1791.
7. Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol 1992; 54:911-930.
8. Maher F, Vannucci SJ, Simpson IA. Glucose transporter proteins in brain. Faseb J 1994; 8:1003-1011.
9. Olson AL, Pessin JE. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 1996; 16:235-256.
10. Vannucci SJ, Clark RR, Koehler-Stec E, et al. Glucose transporter expression in brain: relationship to cerebral glucose utilization. Dev Neurosci 1998; 20:369-379.
11. Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 1997; 21:2-21.
12. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996; 16:877-885.
13. Abi-Saab WM, Maggs DG, Jones T, et al. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 2002; 22:271-279.
14. Cornford EM, Hyman S, Cornford ME, Caron MJ. Glut1 glucose transporter activity in human brain injury. J Neurotrauma 1996; 13:523-536.
15. Bergsneider M, Hovda DA, Shalmon E, et al. Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. J Neurosurg 1997; 86:241-251.
16. Thomas S, Prins ML, Samii M, Hovda DA. Cerebral metabolic response to traumatic brain injury sustained early in development: a 2-deoxy-D- glucose autoradiographic study. J Neurotrauma 2000; 17:649-665.
17. Yoshino A, Hovda DA, Katayama Y, et al. Hippocampal CA3 lesion prevents postconcussive metabolic dysfunction in CA1. J Cereb Blood Flow Metab 1992; 12:996-1006.
18. Yoshino A, Hovda DA, Kawamata T, et al. Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: evidence of a hyper- and subsequent hypometabolic state. Brain Res 1991; 561:106-119.
19. Hayes RL, Katayama Y, Jenkins LW, et al. Regional rates of glucose utilization in the cat following concussive head injury. J Neurotrauma 1988; 5:121-137.
20. Hovda DA, Yoshino A, Kawamata T, et al. Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study. Brain Res 1991; 567:1-10.
21. Kawamata T, Katayama Y, Hovda DA, et al. Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury. J Cereb Blood Flow Metab 1992; 12:12-24.
22. Bergsneider M, Hovda DA, Lee SM, et al. Dissociation of cerebral glucose metabolism and level of consciousness during the period of metabolic depression following human traumatic brain injury. J Neurotrauma 2000; 17:389-401.
23. Bergsneider M, Hovda DA, McArthur DL, et al. Metabolic recovery following human traumatic brain injury based on FDG-PET: time course and relationship to neurological disability. J Head Trauma Rehabil 2001; 16:135-148.
24. Glenn TC, Kelly DF, Boscardin WJ, et al. Energy dysfunction as a predictor of outcome after moderate or severe head injury: indices of oxygen, glucose, and lactate metabolism. J Cereb Blood Flow Metab 2003; 23:1239-1250.
25. Vespa PM, McArthur D, O'Phelan K, et al. Persistently low extracellular glucose correlates with poor outcome 6 months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab 2003; 23:865-877.
26. Vink R, Faden AI, McIntosh TK. Changes in cellular bioenergetic state following graded traumatic brain injury in rats: determination by phosphorus 31 magnetic resonance spectroscopy. J Neurotrauma 1988; 5:315-330.
27. Vespa P, Bergsneider M, Hattori N, et al. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab 2005; 25:763-774.
28. Parkin M, Hopwood S, Jones DA, et al. Dynamic changes in brain glucose and lactate in pericontusional areas of the human cerebral cortex, monitored with rapid sampling on-line microdialysis: relationship with depolarisation-like events. J Cereb Blood Flow Metab 2005; 25:402-413.
29. Czech MP, Corvera S. Signalling mechanisms that regulate glucose transport. J Biol Chem 1999; 274:1865-1868.
30. Schulingkamp RJ, Pagano TC, Hung D, Raffa RB. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2000; 24:855-872.
31. Seaquist ER, Damberg GS, Tkac I, Gruetter R. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 2001; 50:2203-2209.
32. Hillered L, Vespa PM, Hovda DA. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 2005; 22:3-41.
33. Hillered L, Persson L. Neurochemical monitoring of the acutely injured human brain. Scand J Clin Lab Invest Suppl 1999; 229:9-18.
34. Hillered L, Persson L, Nilsson P, et al. Continuous monitoring of cerebral metabolism in traumatic brain injury: a focus on cerebral microdialysis. Curr Opin Crit Care 2006; 12:112-118.
35. Sarrafzadeh AS, Sakowitz OW, Callsen TA, et al. Bedside microdialysis for early detection of cerebral hypoxia in traumatic brain injury. Neurosurg Focus 2000; 9:e2.
36. Sarrafzadeh AS, Sakowitz OW, Kiening KL, et al. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit Care Med 2002; 30:1062-1070.
37. Sarrafzadeh AS, Kiening KL, Callsen TA, Unterberg AW. Metabolic changes during impending and manifest cerebral hypoxia in traumatic brain injury. Br J Neurosurg 2003; 17:340-346.
38. Sarrafzadeh A, Haux D, Sakowitz O, et al. Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke 2003; 34:1382-1388.
39. Sarrafzadeh A, Haux D, Plotkin M, et al. Bedside microdialysis reflects dysfunction of cerebral energy metabolism in patients with aneurysmal subarachnoid hemorrhage as confirmed by 15 O-H2 O-PET and 18 F-FDG-PET. J Neuroradiol 2005; 32:348-351.
40. Bellander BM, Cantais E, Enblad P, et al. Consensus meeting on microdialysis in neurointensive care. Intensive Care Med 2004; 30:2166-2169.
41. Maggs DG, Borg WP, Sherwin RS. Microdialysis techniques in the study of brain and skeletal muscle. Diabetologia 1997; 40 (Suppl 2):S75-S82.
42. Gruetter R, Novotny EJ, Boulware SD, et al. Noninvasive measurements of the cerebral steady-state glucose concentration and transport in humans by 13C nuclear magnetic resonance. Adv Exp Med Biol 1993; 331:35-40.
43. Hopwood SE, Parkin MC, Bezzina EL, et al. Transient changes in cortical glucose and lactate levels associated with peri-infarct depolarisations, studied with rapid-sampling microdialysis. J Cereb Blood Flow Metab 2005; 25:391-401.
44. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 2007; 35:2262-2267.
45. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006; 34:96-101.
46. Badjatia N, Topcuoglu MA, Buonanno FS, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2005; 33:1603-1609.
47. Bruno A, Biller J, Adams HP Jr, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999; 52:280-284.
48. Frontera JA, Fernandez A, Claassen J, et al. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 2006; 37:199-203.
49. Jeremitsky E, Omert LA, Dunham CM, et al. The impact of hyperglycemia on patients with severe brain injury. J Trauma 2005; 58:47-50.
50. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000; 46:335-342; discussion 342-343.
51. Vespa P, Boonyaputthikul R, McArthur DL, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 2006; 34:850-856.
52. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64:1348-1353.
53. Bilotta F, Spinelli A, Giovannini F, et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007; 19:156-160. This single-center prospective randomized study found no impact of intensive insulin therapy on the rate of neurological complications and on the outcome of patients with subarachnoid hemorrhage.